UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
______________
FORM
8-K
______________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): June 3, 2010
OCULUS
INNOVATIVE SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
001-33216
|
68-0423298
|
|
(State
or Other Jurisdiction
|
(Commission
|
(I.R.S.
Employer
|
|
of
Incorporation)
|
File
Number)
|
Identification
No.)
|
1129
N. McDowell Blvd, Petaluma, CA 94954
(Address
of principal executive offices)(Zip Code)
(707)
782-0792
(Registrants
telephone number, including area code)
N/A
(Former
name of former address if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
2.02 Results
of Operations and Financial Condition.
On June
3, 2010, Oculus Innovative Sciences, Inc. issued a press release announcing
financial results for its fiscal quarter ended and fiscal year ended March 31,
2010. The full text of the press release is furnished as Exhibit
99.1.
Item
9.01 Financial
Statements and Exhibits
Exhibits
99.1 Press
Release issued by Oculus Innovative Sciences, Inc. dated June 3,
2010.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Date:
June 3, 2010
|
/s/
Robert Miller
|
|
|
(Signature)
|
|
|
Name:
Robert
Miller
|
|
|
Title:
Chief
Financial Officer
|